Elin Hadler-Olsen

Dr. Elin Hadler-Olsen


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2013 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
EHElin Hadler-Olsen
Elin Hadler-Olsen
JWJan-Olof Winberg
Jan-Olof Winberg
LULars Uhlin-Hansen
Lars Uhlin-Hansen

23 August 2014 in BMC Clinical Pathology
Verified
Journal Article
Open access
PDF file
AWAnna M Wirsing
Anna M Wirsing
OROddveig G Rikardsen
Oddveig G Rikardsen
SSSonja Eriksson Steigen
Sonja Eriksson Steigen
LULars Uhlin-Hansen
Lars Uhlin-Hansen
EHElin Hadler-Olsen
Elin Hadler-Olsen
Oral squamous cell carcinomas are often heavily infiltrated by immune cells. The organization of B-cells, follicular dendritic cells, T-cells and high-endothelial venules into structures termed tertiary lymphoid structures have been detected in various types of cancer, where their presence is found to predict favourable outcome. The purpose of the present study was to evaluate the incidence of tertiary lymphoid structures in oral squamous cell carcinomas, and if present, analyse whether they were associated with clinical outcome.

14 November 2019 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
MOMark Owyong
Mark Owyong
JCJonathan Chou
Jonathan Chou
RBRenske Je van Den Bijgaart
Renske Je van Den Bijgaart
NKNiwen Kong
Niwen Kong
GEGizem Efe
Gizem Efe
VPVicki Plaks
Vicki Plaks
Metastasis, the main cause of cancer-related death, has traditionally been viewed as a late-occurring process during cancer progression. Using the MMTV-PyMT luminal B breast cancer model, we demonstrate that the lung metastatic niche is established early during tumorigenesis. We found that matrix metalloproteinase 9 (MMP9) is an important component of the metastatic niche early in tumorigenesis and promotes circulating tumor cells to colonize the lungs. Blocking active MMP9, using a monoclonal antibody specific to the active form of gelatinases, inhibited endogenous and experimental lung metastases in the MMTV-PyMT model. Mechanistically, inhibiting MMP9 attenuated migration, invasion, and colony formation and promoted CD8+ T cell infiltration and activation. Interestingly, primary tumor burden was unaffected, suggesting that inhibiting active MMP9 is primarily effective during the early metastatic cascade. These findings suggest that the early metastatic circuit can be disrupted by inhibiting active MMP9 and warrant further studies of MMP9-targeted anti-metastatic breast cancer therapy.

27 February 2019 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
EHElin Hadler-Olsen
Elin Hadler-Olsen
AWAnna Maria Wirsing
Anna Maria Wirsing
Background: Various immune cells have been suggested as prognostic markers for cancer patients. In this article, we present a systematic review and meta-analysis of studies assessing the prognostic value of tissue-infiltrating immune cells in oral cancer and discuss the reporting quality of these studies.Methods: We performed a systematic literature search and included studies using immunohistochemistry and survival analysis to assess the prognostic value of tumour-infiltrating T cells, B cells, macrophages, dendritic cells, mast cells and natural killer cells in oral cancer. We performed meta-analysis of studies providing necessary statistical data and investigated the studies’ adherence to the REporting recommendations for tumour MARKer prognostic studies (REMARK) guidelines.Results: Of the 1960 articles identified, 33 were eligible for this systematic review and 8 were included in the meta-analysis. CD163+ M2 macrophages and CD57+ natural killer cells were the most promising predictors of survival in oral cancer patients. Many studies lacked important information on their design and conduct.Conclusion: Deficiencies in the reporting of study design and conduct make it difficult to draw reliable conclusions about the suggested markers. The prognostic value of CD163+ M2 macrophages and CD57+ natural killer cells should be validated in large, standardised studies.

1 June 2018 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
AWAnna Maria Wirsing
Anna Maria Wirsing
IEIda Korsnes Ervik
Ida Korsnes Ervik
MSMarit Seppola
Marit Seppola
LULars Uhlin-Hansen
Lars Uhlin-Hansen
SSSonja Eriksson Steigen
Sonja Eriksson Steigen
EHElin Hadler-Olsen
Elin Hadler-Olsen

9 March 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JWJuliane Winkler
Juliane Winkler
PLPengyuan Liu
Pengyuan Liu
KPKiet Phong
Kiet Phong
JHJohanna H. Hinrichs
Johanna H. Hinrichs
NANassim Ataii
Nassim Ataii
ZWZena Werb
Zena Werb
Significance: Bisphenol A (BPA), found in many plastic products, has weak estrogenic effects that can be harmful to human health. Thus, structurally related replacements—bisphenol S (BPS) and bisphenol F (BPF)—are coming into wider use with very few data about their biological activities. Here, we compared the effects of BPA, BPS, and BPF on human mammary organoids established from normal breast tissue. BPS disrupted organoid architecture and induced supernumerary branching. At a proteomic level, the bisphenols altered the abundance of common targets and those that were unique to each compound. The latter included proteins linked to tumor-promoting processes. These data highlighted the importance of testing the human health effects of replacements that are structurally related to chemicals of concern.